Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 52, Issue 19, Pages 5789-5792Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm9010719
Keywords
-
Categories
Funding
- William Randolph Hearst Foundation
Ask authors/readers for more resources
We report here that nitazoxanide (NTZ) and its active metabolite kill replicating and nonreplicating M. tuberculosis at low mu g/mL levels. NTZ appears to evade resistance, as we were unable to recover resistant colonies, using tip to 10(12) colony forming units. Therefore, NTZ is a novel lead compound that kills replicating and nonreplicating M. tuberculosis by a novel mechanism of action, which appears to bypass the development of resistance.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available